Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence

Hämmig, Robert; Köhler, Wilfried; Bonorden-Kleij, Karin; Weber, Bernd; Lebentrau, Karin; Berthel, Toni; Babic-Hohnjec, Lucija; Vollmert, Christian; Höpner, Doris; Gholami, Najibulah; Verthein, Uwe; Haasen, Christian; Reimer, Jens; Ruckes, Christian (2014). Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence. Journal of substance abuse treatment, 47(4), pp. 275-281. Elsevier 10.1016/j.jsat.2014.05.012

[img] Text
1-s2.0-S0740547214000944-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (235kB)

Opioid substitution treatment (OST) for opioid dependence may be limited by adverse events (AEs). Increasing the range of therapeutic options optimizes outcomes and facilitates patient management. An international, multi-center, two-phase study investigated the efficacy and safety of slow-release oral morphine (SROM) versus methadone in patients receiving methadone therapy for opioid dependence. In phase 1 (two way cross-over, 11 weeks each period) patients were randomized to SROM or methadone oral solution. In phase 2 (25 weeks), patients continued treatment with SROM (group A) or switched from
methadone to SROM (group B). In total, 211 out of 276 completed phase 1 and 198 entered phase 2 (n = 95 group A, n = 103 group B). Treatment with both SROM and methadone was well tolerated. However, the mean QTc-interval associated with methadone was significantly longer than that under SROM. Higher treatment satisfaction, fewer cravings for heroin, and lower mental stress were reported with SROM. This study adds a significant further weight of evidence that SROM is an effective and well tolerated long-term maintenance treatment for opioid dependence with a beneficial risk profile compared to methadone regarding cardiac effects and supports its clinical utility.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > UPD Murtenstrasse

UniBE Contributor:

Hämmig, Robert

ISSN:

0740-5472

Publisher:

Elsevier

Language:

English

Submitter:

Robert Hämmig

Date Deposited:

26 Jan 2015 09:43

Last Modified:

05 Dec 2022 14:39

Publisher DOI:

10.1016/j.jsat.2014.05.012

PubMed ID:

25064422

Uncontrolled Keywords:

Opioid substitution treatment, Slow-release oral morphine, Opioid dependence, QTc-interval, Safety

BORIS DOI:

10.7892/boris.61925

URI:

https://boris.unibe.ch/id/eprint/61925

Actions (login required)

Edit item Edit item
Provide Feedback